Valued at $700.0M at its later-stage round, Sep 2023. Nothing has traded since.
- ·The complete investor list: 24 names
- ·Watch ReCode Therapeutics: the Monday email on marks, rounds and moves
Valuation timeline
0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026Membership and data by Private Market View
ReCode Therapeutics funding history
3 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Sep 2025 | Debt | $29.4M | ▮ | ▮ |
| Oct 2021 | Later Stage VC | $259.8M | ▮ | ▮ |
| Mar 2020 | Early Stage VC | $27.5M | ▮ | ▮ |
Membership and data by Private Market View
ReCode Therapeutics valuation
ReCode Therapeutics was valued at $700 million at its later-stage round in Sep 2023. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.
How much has ReCode Therapeutics raised?
ReCode Therapeutics has raised $388 million across 3 recorded rounds since 2020. The largest was a $29.4 million debt round in Sep 2025.
ReCode Therapeutics has filed 5 Form Ds with the SEC since 2020, most recently in Sep 2023 ($260 million sold to 28 investors).
How ReCode Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For ReCode Therapeutics, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →
Frequently asked about ReCode Therapeutics
- What is ReCode Therapeutics worth?
- ReCode Therapeutics is valued at $700.0M as of Oct 2026. Valued at $700.0M at its later-stage round, Sep 2023. Nothing has traded since.
- How much has ReCode Therapeutics raised?
- ReCode Therapeutics has raised $388.0M in total funding across 3 recorded rounds.
- When did ReCode Therapeutics last raise?
- ReCode Therapeutics last raised in Sep 2025 (Debt), raising $29.4M.